United Therapeutics
UTHR
#1026
Rank
ยฃ16.59 B
Marketcap
ยฃ367.02
Share price
1.08%
Change (1 day)
25.09%
Change (1 year)

Revenue for United Therapeutics (UTHR)

Revenue in 2025 (TTM): ยฃ2.37 Billion

According to United Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ2.34 Billion. In 2024 the company made a revenue of ยฃ2.29 Billion an increase over the revenue in the year 2023 that were of ยฃ1.82 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for United Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ2.37 B3.69%
2024 ยฃ2.29 B25.51%
2023 ยฃ1.82 B14.15%
2022 ยฃ1.60 B28.18%
2021 ยฃ1.24 B14.75%
2020 ยฃ1.08 B-1.51%
2019 ยฃ1.10 B-13.84%
2018 ยฃ1.28 B0.45%
2017 ยฃ1.27 B-1.48%
2016 ยฃ1.29 B31%
2015 ยฃ0.98 B19.51%
2014 ยฃ0.82 B22.22%
2013 ยฃ0.67 B19.48%
2012 ยฃ0.56 B18.54%
2011 ยฃ0.47 B23.3%
2010 ยฃ0.38 B69.68%
2009 ยฃ0.22 B19%
2008 ยฃ0.19 B80.89%
2007 ยฃ0.10 B30.29%
2006 ยฃ81.49 M21.24%
2005 ยฃ67.21 M75.36%
2004 ยฃ38.33 M28.55%
2003 ยฃ29.81 M58.74%
2002 ยฃ18.78 M375.19%
2001 ยฃ3.95 M187.92%
2000 ยฃ1.37 M343.71%
1999 ยฃ0.3 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
ยฃ44.56 B 1,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ21.81 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.58 B 436.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
ยฃ47.09 B 1,906.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ8.26 B 252.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
ยฃ65.41 M-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.76 B 1,253.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
ยฃ175.75 B 7,389.77%๐Ÿ‡บ๐Ÿ‡ธ USA